Trademark: 79128751
Word
ACTAVIS PHARMACEUTICALS
Status Date
Tuesday, November 22, 2022
Registration Number
4673382
Registration Date
Tuesday, January 20, 2015
Filing Date
Wednesday, November 21, 2012
Published for Opposition
Tuesday, September 10, 2013
Cancellation Date
Tuesday, November 22, 2022
41 Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development
5 Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use. pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
3 Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
1 Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
42 Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
Jun 12, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jun 11, 2023
Death Of International Registration
Oct 22, 2022
New Representative At Ib Received
Aug 15, 2022
Total Invalidation Processed By The Ib
Jul 20, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Jul 19, 2022
Invalidation Processed
Apr 6, 2022
Total Invalidation Of Reg Ext Protection Created
Aug 6, 2021
Cancelled Section 71
Jan 20, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 12, 2015
Final Decision Transaction Processed By Ib
May 28, 2015
Final Disposition Notice Sent To Ib
May 28, 2015
Final Disposition Processed
Apr 20, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jan 20, 2015
Registered-Principal Register
Dec 17, 2014
Ttab Release Case To Trademarks
Dec 17, 2014
Opposition Terminated No. 999999
Dec 17, 2014
Opposition Dismissed No. 999999
May 29, 2014
Refusal Processed By Ib
May 8, 2014
Opposition Notice (Ib Refusal) Sent To Ib
May 6, 2014
Opposition Notice (Ib Refusal) Created
Mar 4, 2014
Opposition Instituted No. 999999
Oct 3, 2013
Extension Of Time To Oppose Received
Sep 16, 2013
Notification Processed By Ib
Sep 10, 2013
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2013
Published For Opposition
Aug 28, 2013
Notification Of Possible Opposition Sent To Ib
Aug 28, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 21, 2013
Notification Of Notice Of Publication E-Mailed
Aug 6, 2013
Law Office Publication Review Completed
Aug 5, 2013
Approved For Pub - Principal Register
Jul 25, 2013
Teas/Email Correspondence Entered
Jul 24, 2013
Correspondence Received In Law Office
Jul 24, 2013
Teas Response To Office Action Received
Jul 22, 2013
Data Modification Completed
Jul 22, 2013
Assigned To Lie
Jul 21, 2013
Attorney Review Completed
Jul 16, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 16, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2013
Correction From Ib Entered - Attorney Review Required
Jul 6, 2013
Correction Transaction Received From Ib
Jun 8, 2013
Refusal Processed By Ib
May 15, 2013
Non-Final Action Mailed - Refusal Sent To Ib
May 15, 2013
Refusal Processed By Mpu
May 15, 2013
Non-Final Action (Ib Refusal) Prepared For Review
May 14, 2013
Non-Final Action Written
May 7, 2013
Application Filing Receipt Mailed
May 3, 2013
Assigned To Examiner
May 3, 2013
New Application Office Supplied Data Entered
May 2, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
